Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0.942. It has been cited 28 times, with 24 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0.437
From 19 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 24 citers.
Center for Scientific Review
Grant: P30 CA008748
Center for Scientific Review
Grant: R01 CA204924
Center for Scientific Review
Grant: R01 CA220524
Center for Scientific Review
Grant: R01 CA235667
Center for Scientific Review
Grant: R01 CA236615
Center for Scientific Review
Grant: R21 CA250478
U.S. Department of Defense
Grant: CA180889
U.S. Department of Defense
Grant: CA200437
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA236615-02
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
National Institutes of Health
Grant: 3R01CA204924-04S1
Enhancement of T cell therapy by incorporating adjunct treatment strategies
National Institutes of Health
Grant: 5R01CA220524-04
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
National Institutes of Health
Grant: 5R01CA235667-02
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
National Institutes of Health
Grant: 1R21CA250478-01A1
Secretable theranostic payloads to augment the efficacy of adoptive CAR-T cell therapies
Experimental Therapeutdics Center of Memorial Sloan Kettering Cancer Center
Commonwealth Foundation for Cancer Research Foundation
Mr. William H. Goodwin and Alice Goodwin
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals